RITA
Selleck Chemicals
SKU:S2781-5MG
Couldn't load pickup availability

RITA is an activator of p53 used in studies of Apoptosis. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and cell cycle models.
By activating p53, RITA can be used to examine caspase-associated cell-death signaling and survival decisions. This context is compatible with apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving p53
- Pathway perturbation studies connected to Apoptosis
- Gain-of-function pathway-activation studies
- Phenotypic profiling in apoptosis, cancer, and cell cycle models
Overall, RITA is appropriate when a defined chemical perturbant is needed to connect p53 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- p53
- Target Class:
- Other
- Pathways:
- Apoptosis
- Research Area:
- Apoptosis • Cancer • Cell Cycle
- CAS No.:
- 213261-59-7
- Molecular Weight:
- 292.37
- Formula:
- C₁₄H₁₂O₃S₂
- SMILES:
- C1=C(SC(=C1)C2=CC=C(O2)C3=CC=C(S3)CO)CO
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.